Skip to main content
Top
Published in: International Journal of Hematology 1/2010

01-07-2010 | Case Report

Primary gastric plasmacytoma associated with Helicobacter pylori infection: a report of two cases with different prognosis

Authors: Hong-sheng Lu, Yun-feng Xu, Mei-fu Gan

Published in: International Journal of Hematology | Issue 1/2010

Login to get access

Abstract

We describe two cases of primary gastric plasmacytoma (GP) associated with Helicobacter pylori infection. Case 1 was that of a 58-year-old man with epigastric pain. H. pylori was eradicated before surgical resection was performed, and after the therapy, the tumor size was reduced. A postoperative pathological examination revealed that the tumor was in early stage and histological grade was grade 1. After 44 months of operation, the patient was in complete remission with no evidence of local relapse or progression to systemic MM. Case 2 was that of a 70-year-old woman with a history of melena. H. pylori eradication was not presented preoperatively. The resected specimen showed the tumor was in advanced stage and histological grade 3. GP eventually progressed to MM and she died of pulmonary infection. In our opinion, GP cannot be eradicated with H. pylori eradication, but disease progression can be effectively controlled to a certain extent. The prognosis of this disease is relatively fair when treated at an early stage. In addition to the treatment, the difference in prognosis could be associated with age, the stage of the tumor, and histological grade.
Literature
1.
go back to reference Kikuchi T, Noguchi T, Yamanami H, Suzuki M, Suzuki S, Kagaya H, et al. A case of primary gastric plasmacytoma. Nippon Shokakibyo Gakkai Zasshi. 2005;102(6):687–92.PubMed Kikuchi T, Noguchi T, Yamanami H, Suzuki M, Suzuki S, Kagaya H, et al. A case of primary gastric plasmacytoma. Nippon Shokakibyo Gakkai Zasshi. 2005;102(6):687–92.PubMed
2.
go back to reference Kyle RA, Rajkumar SV. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia. 2009;23:3–9.CrossRefPubMed Kyle RA, Rajkumar SV. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia. 2009;23:3–9.CrossRefPubMed
3.
go back to reference Yoon SE, Ha HK, Lee YS, Kim PN, Lee MG, Yu E, et al. Upper gastrointestinal series and CT findings of primary gastric plasmacytoma: report of two cases. Am J Roentgenol. 1999;173(5):1266–8. Yoon SE, Ha HK, Lee YS, Kim PN, Lee MG, Yu E, et al. Upper gastrointestinal series and CT findings of primary gastric plasmacytoma: report of two cases. Am J Roentgenol. 1999;173(5):1266–8.
4.
go back to reference Chim CS, Wong WM, Nicholls J, Chung LP, Liang R. Extramedullary sites of involvement in hematologic malignancies: case 3. Hemorrhagic gastric plasmacytoma as the primary presentation in multiple myeloma. J Clin Oncol. 2002;20(1):344–7.PubMed Chim CS, Wong WM, Nicholls J, Chung LP, Liang R. Extramedullary sites of involvement in hematologic malignancies: case 3. Hemorrhagic gastric plasmacytoma as the primary presentation in multiple myeloma. J Clin Oncol. 2002;20(1):344–7.PubMed
5.
go back to reference Susnerwala SS, Shanks JH, Banerijee JH, Scarffe JH, Farrington WT, Slevin NJ. Extramedullary plasmacytoma of the head and the neck region: clinicopathological correlation in 25 cases. Br J Cancer. 1997;75(6):921–7.PubMed Susnerwala SS, Shanks JH, Banerijee JH, Scarffe JH, Farrington WT, Slevin NJ. Extramedullary plasmacytoma of the head and the neck region: clinicopathological correlation in 25 cases. Br J Cancer. 1997;75(6):921–7.PubMed
6.
go back to reference Todorovic M, Balint B, Jevtic M, Suvajdzic N, Ceric A, Stamatovic D, et al. Primary gastric mucosa associated lymphoid tissue lymphoma: clinical data predicted treatment outcome. World J Gastroenterol. 2008;14(15):2388–93.CrossRefPubMed Todorovic M, Balint B, Jevtic M, Suvajdzic N, Ceric A, Stamatovic D, et al. Primary gastric mucosa associated lymphoid tissue lymphoma: clinical data predicted treatment outcome. World J Gastroenterol. 2008;14(15):2388–93.CrossRefPubMed
7.
go back to reference Wöhrer S, Isaacson PG, Raderer M. Complete regression of primary gastric plasmacytoma following Helicobacter pylori eradication. Ann Hematol. 2004;83(10):666.CrossRefPubMed Wöhrer S, Isaacson PG, Raderer M. Complete regression of primary gastric plasmacytoma following Helicobacter pylori eradication. Ann Hematol. 2004;83(10):666.CrossRefPubMed
8.
go back to reference Papadaki HA, Skordilis P, Minadakis G, Roussomoustakaki M, Katrinakis G, Psyllaki M, et al. Complete regression of primary gastric plasmacytoma following Helicobacter pylori eradication. Ann Hematol. 2003;82(9):589–92.CrossRefPubMed Papadaki HA, Skordilis P, Minadakis G, Roussomoustakaki M, Katrinakis G, Psyllaki M, et al. Complete regression of primary gastric plasmacytoma following Helicobacter pylori eradication. Ann Hematol. 2003;82(9):589–92.CrossRefPubMed
9.
go back to reference Stasi R, Evangelista ML, Brunetti M. Primary gastric plasmacytoma and Helicobacter pylori infection. J Clin Oncol. 2009;27(1):150–3.CrossRefPubMed Stasi R, Evangelista ML, Brunetti M. Primary gastric plasmacytoma and Helicobacter pylori infection. J Clin Oncol. 2009;27(1):150–3.CrossRefPubMed
10.
go back to reference Kato K, Sugitani M, Nagata T. A case of gastric plasmacytoma associated with Helicobacter pylori infection: improvement of abnormal endoscopic and EUS findings after H. pylori eradication. Gastrointest Endosc. 2001;53(3):352–5.PubMed Kato K, Sugitani M, Nagata T. A case of gastric plasmacytoma associated with Helicobacter pylori infection: improvement of abnormal endoscopic and EUS findings after H. pylori eradication. Gastrointest Endosc. 2001;53(3):352–5.PubMed
11.
go back to reference Gonzalez Cueto D, Bruno S, Bustos Fernandez LM, Narbaitz M. Gastric solitary plasmacytoma associated with Helicobacter pylori infection. Acta Gastroenterol Latinoam. 1999;29:119–23 (in Spanish).PubMed Gonzalez Cueto D, Bruno S, Bustos Fernandez LM, Narbaitz M. Gastric solitary plasmacytoma associated with Helicobacter pylori infection. Acta Gastroenterol Latinoam. 1999;29:119–23 (in Spanish).PubMed
12.
go back to reference Shapiro M, Kimchi NA, Herbert M, Scapa E. Gastric plasmacytoma and Helicobacter pylori infection. J Clin Gastroenterol. 2005;39:56–7.PubMed Shapiro M, Kimchi NA, Herbert M, Scapa E. Gastric plasmacytoma and Helicobacter pylori infection. J Clin Gastroenterol. 2005;39:56–7.PubMed
13.
go back to reference Minami T, Nishimura S, Asagoe K. Primary gastric plasmacytoma at an early stage: unremarkable effect of eradication of Helicobacter pylori. Intern Med. 2003;42(4):370–2.CrossRefPubMed Minami T, Nishimura S, Asagoe K. Primary gastric plasmacytoma at an early stage: unremarkable effect of eradication of Helicobacter pylori. Intern Med. 2003;42(4):370–2.CrossRefPubMed
14.
go back to reference Morita T, Tamura S, Yokoyama Y, Tadokoro T, Higashidani Y, Yamada T, et al. A case of early-stage gastric plasmacytoma. J Gastroenterol. 2002;37:398–401.CrossRefPubMed Morita T, Tamura S, Yokoyama Y, Tadokoro T, Higashidani Y, Yamada T, et al. A case of early-stage gastric plasmacytoma. J Gastroenterol. 2002;37:398–401.CrossRefPubMed
15.
go back to reference Vicuña Arregui M, Borobio Aguilar E, Vila Costas JJ, Viguria Alegría MC, Arrechea Irigoyen M, Borda Celaya F, et al. Gastric plasmacytoma as an uncommon cause of upper gastrointestinal bleeding. Gastroenterol Hepatol. 2008;31(4):217–20.CrossRefPubMed Vicuña Arregui M, Borobio Aguilar E, Vila Costas JJ, Viguria Alegría MC, Arrechea Irigoyen M, Borda Celaya F, et al. Gastric plasmacytoma as an uncommon cause of upper gastrointestinal bleeding. Gastroenterol Hepatol. 2008;31(4):217–20.CrossRefPubMed
Metadata
Title
Primary gastric plasmacytoma associated with Helicobacter pylori infection: a report of two cases with different prognosis
Authors
Hong-sheng Lu
Yun-feng Xu
Mei-fu Gan
Publication date
01-07-2010
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 1/2010
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-010-0587-8

Other articles of this Issue 1/2010

International Journal of Hematology 1/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine